As the global orthopedic devices market is projected to reach $64 billion by 2026, the demand for high-precision Tibial Locking Plates has surged. Hospitals and distributors in South America (30%), Southeast Asia (20%), and Western Europe (20%) are increasingly looking toward China for high-volume, high-quality titanium implants that balance cost-efficiency with uncompromising clinical safety.
Modern tibial fractures—ranging from proximal plateau bursts to distal pilon fractures—require implants that mimic natural bone morphology. Our plates utilize Ti-6Al-4V ELI (Grade 5) titanium alloy, ensuring superior biocompatibility and fatigue resistance. The multi-axial locking mechanism allows surgeons to direct screws precisely to avoid articular surfaces while maintaining rigid stability.
With 69 dedicated QA/QC inspectors and a legacy starting in 2004, KaiSo maintains a 100% inspection protocol. From raw material traceability to the final sterile packaging, every tibial plate conforms to ISO 13485 and CE MDR standards, ensuring that surgeons can trust the mechanical integrity of every screw and plate interface.
The orthopedic industry is shifting from "one-size-fits-all" to "patient-specific" solutions. As a leading exporter, we provide a macro-level solution that integrates 3D anatomical modeling with mass-production efficiency. This approach addresses the global shortage of high-tier orthopedic implants in emerging markets while providing Western Europe with a reliable secondary supply chain that meets the stringent MDR (Medical Device Regulation) requirements.
Our industrial status as a "Top Supplier" is rooted in our 22-year trajectory. We don't just export products; we export clinical reliability. By utilizing automated CNC machining centers and advanced surface treatment (Anodic Oxidation), we reduce the risk of infection and metal sensitivity in patients, providing a long-term commercial advantage for our global distribution partners.
Integration of bioactive coatings (Hydroxyapatite) to accelerate osseointegration in osteoporotic patients. We are currently testing plates that release localized antimicrobial agents to prevent Biofilm formation.
Developing AI-driven surgical planning software that pairs with our tibial locking sets. This allows for pre-operative screw length selection and plate contouring simulation, reducing time in the O.R. by up to 25%.
Transitioning to 100% recyclable titanium scraps and eco-friendly sterilization packaging, aligning with the "Green Hospital" initiatives spreading across the European and North American markets.
KaiSo has established a complete Quality Assurance System to continuously fulfil the requirements according to ISO9001, 13485, CE, ranging from material procurement to design development and automated production processes.
Navigating the complex waters of medical device registration is our forte. We provide full technical dossiers for FDA (USA), CE MDR (Europe), and ANVISA (Brazil). Our internal regulatory affairs team ensures that all Tibial Locking Plates meet the specific biocompatibility and mechanical testing requirements of the local jurisdiction.
With 59 R&D engineers, we offer "Light Customization" and "Sample Processing." Whether you need a specific plate geometry for a unique demographic or private labeling for your brand, our automated production lines can pivot to meet your specifications without compromising lead times.
ISO13485 (SX 2180356-1)
93/42/EEC (CE Certified)
MDR Compliant
KaiSo Medical
